A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions

Ovarian CancerBiomarker

Interventions

GENETIC

Sequencing of DNA, RNA, and Proteins

Sequencing of DNA, RNA, and Proteins for Tumor, Blood, Ascite, and other samples before and after treatment.

Trial Locations (1)

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER

NCT06483425 - A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer | Biotech Hunter | Biotech Hunter